Intraoperative Optical Coherence Tomography - Normals
This study is looking at a non-invasive imaging test called Optical Coherence Tomography (OCT) to see if new versions of this technology can improve how doctors detect eye diseases. OCT uses light waves to take detailed pictures of the back of your eye (retina). Researchers want to test these new OCT technologies on healthy adults to make sure they work well before using them in patients with eye conditions. The goal is to make OCT imaging faster and clearer to help doctors diagnose eye diseases more accurately. This is an observational study, meaning you won't receive any treatment, and it aims to enroll 20 healthy volunteers.
- Study design
- This is an observational study that plans to enroll 20 healthy adult volunteers. It is not specified if it is randomized or blinded.
- What's involved
- You may be asked to participate in optional follow-up imaging sessions for an average of 2 years.
- Compensation
- Not stated in the trial record.
- Follow-up
- You may have optional follow-up imaging for an average of 2 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Intraoperative Optical Coherence Tomography - Normals
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Novel Ophthalmic Diagnostics using Optical Coherence TomographySubjects enrolled in the study may periodically be asked to participate in follow-up imaging during the duration of the study. These follow-up sessions will be optional through study completion, an average of 2 years.
This study will develop novel OCT technology for improved diagnostic sensitivity in ophthalmology. Specifically, we will develop novel OCT imaging and image-processing methods to improve imaging speed and quality. Successful completion of this project will improve clinical diagnostics of ophthalmic diseases. Pre-clinical validation of system performance and ergonomics is a valuable step is clinical imaging technology development. We will evaluate imaging performance for system iterations on next-generation ophthalmic OCT imaging technologies over current-generation imaging systems on healthy adult volunteers prior to clinical translation. While system resolution, contrast, and speed can be (and will be) evaluated using calibration standards and phantoms, in vivo human imaging in healthy subjects is necessary to establish a baseline for system performance and image quality prior to clinical translation.